GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
Company Details
- Employees
- 35
- Address
- 송파구 송파대로 167 문정역테라타워 A동 1116호, 서울,seoul 05855,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gi-innovation.com
- HQ
- 서울, Seoul
Gi Innovation Questions
Gi Innovation's website is gi-innovation.com
Gi Innovation's LinkedIn profile is https://kr.linkedin.com/company/gi-innovation
Gi Innovation has
35 employees.
View email and phone details for 35
employees at Gi Innovation.
Gi Innovation's industry is
Biotechnology Research
Gi Innovation's top competitors are
Gi Cell (지아이셀),
Aptabio,
Onconic Therapeutics,
Daehwa Pharmaceutical Co., Ltd.,
Yuhan Corporation,
Hanmi Pharmaceutical (한미약품),
Idience,
Researchmentor,
Hk Inno-N,
Boryung.
Gi Innovation's categories are Biotechnology Research
